Horová E, Prázný M, Kaňková K, Brismar K, Gu H F
Third Department of Medicine - Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, Czech Republic.
Folia Biol (Praha). 2012;58(3):121-7.
Evidence has recently indicated that the MRAS and HNF1A genetic polymorphisms are associated with coronary artery disease. The MRAS and HNF1A genes are located on chromosomes 3q and 12q within the regions where associations with diabetes and diabetic nephropathy occur. We thus performed genetic and functional analyses of these two genes to evaluate their impacts on diabetes and diabetic nephropathy. MRAS and HNF1A genetic polymorphisms were genotyped in 1399 Czech subjects including non-diabetic controls (339), type 1 (243) and type 2 (817) diabetic patients with and without diabetic nephropathy using TaqMan allelic discrimination. Gene expression levels in the kidneys of diabetic Goto-Kakizaki and Wistar rats were detected with real-time RT-PCR. Despite no significance in genetic analysis of diabetic subjects, SNP rs2259816 in the HNF1A gene tended to associate with diabetic nephropathy in type 1 diabetic patients. The hnf1a gene expression was significantly decreased in kidney tissues of Goto-Kakizaki rats compared to Wistar and insulin-treated Goto-Kakizaki rats. There was neither significant association in the MRAS genetic polymorphism with diabetic nephropathy nor variation of mras gene expression in the kidneys of Goto-Kakizaki and Wistar rats. Data from the present study have not proved any significant association of the MRAS and HNF1A genetic polymorphisms with diabetes and diabetic nephropathy in a cohort of Czech population. However, the functional analysis and the trend in genetic analysis suggest that the HNF1A gene may have primary genetic impact on the development of diabetic nephropathy.
最近有证据表明,MRAS和HNF1A基因多态性与冠状动脉疾病有关。MRAS和HNF1A基因位于3号染色体q臂和12号染色体q臂上,这些区域与糖尿病及糖尿病肾病存在关联。因此,我们对这两个基因进行了基因和功能分析,以评估它们对糖尿病和糖尿病肾病的影响。我们使用TaqMan等位基因鉴别技术,对1399名捷克受试者(包括非糖尿病对照组339人、1型糖尿病患者243人、2型糖尿病患者817人,其中部分患者伴有或不伴有糖尿病肾病)的MRAS和HNF1A基因多态性进行了基因分型。采用实时逆转录聚合酶链反应检测糖尿病Goto-Kakizaki大鼠和Wistar大鼠肾脏中的基因表达水平。尽管在糖尿病受试者的基因分析中未发现显著差异,但HNF1A基因中的SNP rs2259816在1型糖尿病患者中倾向于与糖尿病肾病相关。与Wistar大鼠及胰岛素治疗的Goto-Kakizaki大鼠相比,Goto-Kakizaki大鼠肾脏组织中的hnf1a基因表达显著降低。MRAS基因多态性与糖尿病肾病之间既无显著关联,Goto-Kakizaki大鼠和Wistar大鼠肾脏中的mras基因表达也无变化。本研究的数据尚未证明在捷克人群队列中,MRAS和HNF1A基因多态性与糖尿病及糖尿病肾病存在任何显著关联。然而,功能分析和基因分析趋势表明,HNF1A基因可能对糖尿病肾病的发生具有主要遗传影响。